Critical organ dosimetry in permanent seed prostate brachytherapy: Defining the organs at risk
- 31 December 2005
- journal article
- research article
- Published by Elsevier in Brachytherapy
- Vol. 4 (3) , 186-194
- https://doi.org/10.1016/j.brachy.2005.01.002
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Influence of prostate volume on dosimetry results in real-time 125I seed implantationInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Probability of late rectal morbidity in 125I prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2003
- American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Dosimetric and radiographic correlates to prostate brachytherapy-related rectal complications.International Journal of Cancer, 2001
- Defining the risk of developing Grade 2 proctitis following 125I prostate brachytherapy using a rectal dose–volume histogram analysisInternational Journal of Radiation Oncology*Biology*Physics, 2001
- The effect of constipation on rectal dosimetry following prostate brachytherapyMedical Dosimetry, 2000
- The american brachytherapy society recommendations for permanent prostate brachytherapy postimplant dosimetric analysisInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Effect of post-implant edema on the rectal dose in prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Rectal dosimetric analysis following prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 1999